Delivery Order SPE2DB24D1205-SPE2DB25FCYNC
- Not listed
- The Defense Logistics Agency awarded a $52,670.24 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $67,384.37 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, which is firm fixed price with no set-aside designation, was competitively awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a $62,114.93 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of May 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $68,437.63 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order draws from AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals...
- The Defense Logistics Agency awarded a delivery order valued at $138,315.26 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $52,149.01 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitive, non-set-aside contract carries a firm fixed price and was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,704.11 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, and represents a non-competitive set-aside. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $15,850.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 14, 2025. This non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $34,953.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical supply. The contract, executed on September 17, 2025, represents a non-competitive delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYNCDelivery Order
The Defense Logistics Agency awarded a $38,655.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector medication. The contract, which was not set aside and was competitively awarded, was finalized on July 14, 2025, with an ultimate completion date of July 15, 2025. AmerisourceBergen will perform this delivery order from its corporate headquarters location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains through competitive procurement processes. This delivery order for Enbrel, a biologic treatment commonly used for rheumatoid arthritis and other autoimmune conditions, exemplifies the company's role in supplying specialized pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.7k | 7/14/25 |